Reece, D. E., Hegenbart, U., Sanchorawala, V., Merlini, G., Palladini, G., Bladé, J., . . . Comenzo, R. L. (2014). Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis. Blood, 124(16), . https://doi.org/10.1182/blood-2014-04-568329
Chicago Style (17th ed.) CitationReece, Donna E., et al. "Long-term Follow-up from a Phase 1/2 Study of Single-agent Bortezomib in Relapsed Systemic AL Amyloidosis." Blood 124, no. 16 (2014). https://doi.org/10.1182/blood-2014-04-568329.
MLA (9th ed.) CitationReece, Donna E., et al. "Long-term Follow-up from a Phase 1/2 Study of Single-agent Bortezomib in Relapsed Systemic AL Amyloidosis." Blood, vol. 124, no. 16, 2014, https://doi.org/10.1182/blood-2014-04-568329.
Warning: These citations may not always be 100% accurate.